LABL up +5.66% percent right now. $LABL High is at 54.94

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
LABL up +5.66% percent right now. $LABL High is at 54.94 and the Low 50.08 with current volume of 225,300.

Recent News posted below.

LABL Multi-Color Corp Recent Headline News

Multi-Color posts 2Q profit
Automated Insights - Fri Nov 07, 7:45AM CST
BATAVIA, Ohio (AP) _ Multi-Color Corp. (LABL) on Friday reported profit of $11.3 million in its fiscal second quarter.
LABL: 52.24 (+2.80)

Multi-Color Corporation Announces Record Core EPS at $0.93 for September Quarter
Thomson Reuters ONE - Fri Nov 07, 7:30AM CST
CINCINNATI, OHIO, November 7, 2014 - Multi-Color Corporation (NASDAQ: LABL) today announced second quarter fiscal 2015 results.
LABL: 52.24 (+2.80)

Multi-Color Corporation Declares Quarterly Dividend
Thomson Reuters ONE - Mon Nov 03, 2:00PM CST
Cincinnati, OH - November 3, 2014 - Multi-Color Corporation (NASDAQ:LABL) announced today that its Board of Directors declared the Company's quarterly cash dividend for the third quarter of fiscal year 2015. The dividend is a payment of five cents per common share, payable December 1, 2014, to shareholders of record at the close of business on November 17, 2014.
LABL: 52.24 (+2.80)

Multi-Color Corporation Announces Date of Second Quarter Fiscal Year 2015 Financial Results Conference Call and Webcast
Thomson Reuters ONE - Fri Oct 24, 1:52PM CDT
CINCINNATI, OHIO, October 24, 2014 -- Multi-Color Corporation (NASDAQ:LABL) will announce Second Quarter Fiscal Year 2015 financial results on Friday, November 7, 2014 at 8:30 a.m. (ET) and hold its quarterly conference call on Friday, November 7, 2014 at 10:00 a.m. (ET) to discuss the news release.
LABL: 52.24 (+2.80)

II-VI Incorporated (IIVI) Catches Eye: Stock Jumps 7.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 8:04AM CDT
II-VI Incorporated (IIVI) was a big mover last session, as the company saw its shares rise nearly 8% on the day.
CENX: 28.14 (+0.28), GPK: 12.66 (+0.03), LABL: 52.24 (+2.80), IIVI: 13.34 (+0.04)

Multi-Color Has Returned 31.6% Since SmarTrend Recommendation (LABL)
Comtex SmarTrend(R) - Mon Sep 29, 9:10AM CDT
SmarTrend identified an Uptrend for Multi-Color (NASDAQ:LABL) on May 30th, 2014 at $35.10. In approximately 4 months, Multi-Color has returned 31.56% as of today's recent price of $46.17.
LABL: 52.24 (+2.80)

Hudson Technologies (HDSN) in Focus: Stock Rises 6.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 25, 7:57AM CDT
Hudson Technologies Inc. (HDSN) was a big mover last session, as the company saw its shares rise by over 6% on the day.
HDSN: 4.29 (-0.05), SEE: 38.89 (+0.78), LABL: 52.24 (+2.80)

Lindsay (LNN) Downgraded to Strong Sell on Weak Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 12:50PM CDT
On Sep 24, 2014, Zacks Investment Research downgraded Lindsay Corporation (LNN) to a Zacks Rank #5 (Strong Sell).
LNN: 86.00 (-0.21), ARC: 10.07 (+0.04), LABL: 52.24 (+2.80), ACCO: 8.55 (unch)

29.8% Return Seen to Date on SmarTrend Multi-Color Call (LABL)
Comtex SmarTrend(R) - Fri Sep 12, 10:58AM CDT
SmarTrend identified an Uptrend for Multi-Color (NASDAQ:LABL) on May 30th, 2014 at $35.10. In approximately 4 months, Multi-Color has returned 29.76% as of today's recent price of $45.54.
LABL: 52.24 (+2.80)

Multi-Color Shares Up 34.1% Since SmarTrend's Buy Recommendation (LABL)
Comtex SmarTrend(R) - Fri Sep 05, 9:36AM CDT
SmarTrend identified an Uptrend for Multi-Color (NASDAQ:LABL) on May 30th, 2014 at $35.10. In approximately 3 months, Multi-Color has returned 34.06% as of today's recent price of $47.05.
LABL: 52.24 (+2.80)

What Falling Estimates & Price Mean for Cenveo (CVO) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 7:49AM CDT
Cenveo is a stock to drop as it has witnessed negative trend in earnings estimate revisions and has seen its price decline significantly.
ARC: 10.07 (+0.04), CVO: 1.62 (-0.11), SEE: 38.89 (+0.78), LABL: 52.24 (+2.80)

Willdan Group (WLDN) Jumps: Stock Rises 9.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 04, 7:57AM CDT
Willdan Group, Inc. (WLDN) was a big mover last session, as the company saw its shares rise over 9% on the day.
KALU: 72.35 (+1.58), LABL: 52.24 (+2.80), NNBR: 22.17 (+0.05), WLDN: 15.16 (+0.47)

Adept Technology (ADEP) in Focus: Stock Tanks 19.1% - Tale of the Tape
Zacks Research Stuff - Zacks Investment Research - Wed Aug 27, 7:51AM CDT
Adept Technology stock recorded a sharp decline, falling over 19% in the last trading session
ADEP: 8.18 (unch), LABL: 52.24 (+2.80), SEE: 38.89 (+0.78), NNBR: 22.17 (+0.05)

Falling Earnings Estimates Signal Weakness Ahead for ExOne Company (XONE) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 7:42AM CDT
ExOne Company (XONE) has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter as well as the current year.
SEE: 38.89 (+0.78), LABL: 52.24 (+2.80), XONE: 20.90 (-0.46), BLT: 16.15 (-0.15)

Market-Caps and Stock Selection for Maximum Gains - Screen of the Week
Kevin Matras - ZACKS - Tue Aug 26, 3:11AM CDT
Market-Caps and Stock Selection for Maximum Gains - Screen of the Week
ODFL: 75.12 (-0.13), LABL: 52.24 (+2.80), SEE: 38.89 (+0.78), AKRX: 36.59 (-1.29), ICLR: 52.61 (+0.34), SIMO: 23.57 (-0.66)

Why Multi-Color (LABL) Stock Might be a Great Pick - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Aug 21, 8:00AM CDT
Multi-Color (LABL) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective. It currently has a Zacks Industry Rank of 39 out of more than 250 industries.
LABL: 52.24 (+2.80)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 144

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 175

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 112

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 294

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 507

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 57

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 169

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 116

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 74

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading

Top 5 Most Recently Viewed Articles

Emerie.ai: Transforming Customer Experience in FinTech

Updated Category News Views 489

Introducing Emerie.ai Emerie.ai, formerly known as ENACOMM Financial Services, Inc., represents a significant step forward in the FinTech arena. The company has undergone a rebranding to better reflect its core offering—an Intelligent Virtual Assistant (IVA)—which utilizes cutting-edge artificial intelligence technology. As customer service standards continue to rise,...

Continue Reading
Explore the Groundbreaking JumpCloudLand Conference 2026

Updated Category News Views 183

JumpCloudLand Conference: A New Era for IT Professionals JumpCloud Inc. has launched a remarkable initiative—JumpCloudLand, a comprehensive virtual conference tailored for IT professionals. This dynamic event is set to take place on February 10, 2026, providing a unique opportunity for IT leaders globally to gather and enhance their skills. The nature of IT is...

Continue Reading
General Shale Introduces an Innovative Brick Collection for 2026

Updated Category News Views 220

Innovative Brick Collection from General Shale for 2026 Transforming Spaces with Stylish Brick Designs For years, clay brick has symbolized durability and tradition. General Shale is now revolutionizing brickwork by introducing a new collection that transforms brick into a modern art form, showcasing a range of sizes, textures, and colors. Their contemporary lineup...

Continue Reading
Revolutionary Breakthrough in Gene Therapy for SCN2A Disorders

Updated Category News Views 269

Groundbreaking Research at UCSF Offers New Hope The laboratories led by Dr. Kevin Bender and Dr. Nadav Ahituv have made significant strides in gene therapy through groundbreaking research. Their recent study unveils a compelling new approach to address SCN2A haploinsufficiency, a critical factor linked to various neurodevelopmental disorders and early-onset epilepsy. This...

Continue Reading
FirstEnergy's New Leadership: Brian Tierney Takes Charge

Updated Category News Views 476

FirstEnergy Corporation Welcomes Brian Tierney as Chair FirstEnergy Corp. (NYSE: FE) has announced the appointment of its President and Chief Executive Officer, Brian X. Tierney, as the new Chair of the Board. This change takes effect on a future date, bringing fresh leadership to the company valued at $22.6 billion. Tierney, who has been in the role of President and CEO...

Continue Reading